Subhabrota Majumdar

Dr. Subhabrota Majumdar

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 August 2024 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SGShayeri Chatterjee Ganguly
Shayeri Chatterjee Ganguly
BMBeduin Mahanti
Beduin Mahanti
SGSoumya Ganguly
Soumya Ganguly
SMSubhabrota Majumdar
Subhabrota Majumdar

13 May 2025 in BMC Pharmacology and Toxicology
Verified
Journal Article
Open access
PDF file
SPSusanta Paul
Susanta Paul
SMSubhabrota Majumdar
Subhabrota Majumdar
MCMainak Chakraborty
Mainak Chakraborty
SMSwarupananda Mukherjee
Swarupananda Mukherjee
NSNilanjan Sarkar
Nilanjan Sarkar
SNShamama Nishat
Shamama Nishat
Ocular drug delivery is challenging due to the eye’s unique anatomy and physiology, which limit drug absorption and distribution. Traditional methods like eye drops have poor bioavailability and often require frequent dosing. In-situ gel systems, liquid formulations that transform into a gel upon contact with physiological conditions (pH, temperature, or ions in tear fluid), offer several advantages for ocular drug delivery. Ganciclovir was incorporated into a thermoresponsive in situ gel base. Nine formulations were prepared using the cold technique and a 3² full factorial design. The physical properties of ganciclovir gel, including clarity, pH, viscosity, gelation temperature, and gelation time, were scrutinized. In vitro drug release was assessed using a dialysis membrane method, and ocular toxicity was evaluated in a rabbit model. Poloxamer 407 and HPMC E-50 LV were used to prepare the gel, with the 3² factorial design analyzing the effects of varying concentrations on the gel’s viscosity, gelation temperature, and gelation time. The optimized in-situ gel formulation (Batch B5) contained 15% w/v poloxamer 407 and 1% w/v HPMC E-50 LV, achieving a viscosity of 64.81 cPs, with a gelation temperature of 39.0 °C and a gelation time of 183 s. This formulation demonstrated better permeability and sustained ganciclovir release than a commercial formulation. Ocular toxicity studies confirmed that the formulation was non-irritating and well-tolerated. Overall, the gel showed suitable physical properties, sustained drug release over 12 h, and significant potential for enhancing drug bioavailability and treatment efficacy for ocular infections. These findings confirm that the optimized ganciclovir in situ gel preparation improves eye permeation and prolongs ocular retention time, thus enhancing its therapeutic efficacy. Its sustained release and prolonged retention time make it a promising alternative to conventional eye drops, offering better patient compliance and efficacy.

25 March 2024 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
SGShayeri Chatterjee Ganguly
Shayeri Chatterjee Ganguly
BMBeduin Mahanti
Beduin Mahanti
SGSoumya Ganguly
Soumya Ganguly
SMSubhabrota Majumdar
Subhabrota Majumdar

1 November 2011 in Die Pharmazie
Verified
Journal Article
Closed access
SMSubhabrota Majumdar
Subhabrota Majumdar
SRS. Roy
S. Roy
BGB. Ghosh
B. Ghosh
The aim of the present study was to prepare a colon targeted pellet formulation of secnidazole and to evaluate the formulation in vitro and in vivo by a gamma scintigraphy method. Pectin/ethyl cellulose in different ratios and in different coating labels with plasticizer was used to prepare secnidazole pellets by a powder layering technique. The formulations were tagged with 99mTC-DTPA, a tracer in gamma scintigraphy to evaluate its transit behavior in rabbits. Morphology and compatibility were studied using Scanning Electron Microscopy, IR spectroscopy and Differential Scanning Calorimetry were used for the characterization of prepared pellets. The in-vitro study suggested that pectin (59%) esterification and ethyl cellulose 45cps at 20% coating label led to an optimum bacterial enzyme dependent released behavior. The optimized formulation was subjected to an in-vivo transit study. Scintigraphy images clearly indicated that the formulation can delay the drug release prior to the colon. The average time of gastric emptying and colon arrival was 57 min and 6.08 h, respectively. The coated pellets prepared by powder layering technology successfully released drug in the colon indicating that site specificity has been achieved with pectin 59% esterification and ethyl cellulose 45 cps at 1:2 ratio with 20% coating label.

31 January 2025 in International Journal of Biological Macromolecules
Verified
Journal Article
Closed access
SGShayeri Chatterjee Ganguly
Shayeri Chatterjee Ganguly
SGSoumya Ganguly
Soumya Ganguly
BMBeduin Mahanti
Beduin Mahanti
PPPurna Chandra Pal
Purna Chandra Pal
SDSwarnajit Dutta
Swarnajit Dutta
SMSubhabrota Majumdar
Subhabrota Majumdar

29 December 2025 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Closed access
PDF file
SMSubhabrota Majumdar
Subhabrota Majumdar
SCSailee Chowdhury
Sailee Chowdhury
PMPrasenjit Mondal
Prasenjit Mondal
SJSAJAL KUMAR JHA
SAJAL KUMAR JHA
RMRana Mazumder
Rana Mazumder